Concepedia

Hannah Lingard

HL

8

Publications

813

Citations

8

H-Index

2009

Active since

Affiliations

University of Oxford(Current)

Ludwig Cancer Research

University of Cambridge

Hannah Lingard is an author at University of Oxford specializing in natural sciences, molecular biology, and medicine.

Top concepts

Natural SciencesMedicineMolecular BiologyBiochemistryPeptide ScienceProtein FoldingProtein AssemblyOrganic ChemistryStructural BiologyMedicinal Chemistry

Publications per year

2009–2016

8

Publications

8

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

S. Picaud, Christopher Wells, I. Felletar et al. · Proceedings of the National Academy of Sciences · 2013 · 475 citations · Full text

Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia

S. Picaud, Katharina Leonards, Jean‐Philippe Lambert et al. · Science Advances · 2016 · 108 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +20

[1,2,4]Triazolo[4,3-<i>a</i>]phthalazines: Inhibitors of Diverse Bromodomains

O. Fedorov, Hannah Lingard, Christopher Wells et al. · Journal of Medicinal Chemistry · 2013 · 98 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Bet Bromodomains +13

Diphenylacetylene‐Linked Peptide Strands Induce Bidirectional β‐Sheet Formation

Hannah Lingard, Jeongmin Han, Amber L. Thompson et al. · Angewandte Chemie International Edition · 2014 · 44 citations

Protein Chemistry, Protein Assembly, Biochemistry +14

Highly Potent, Orally Available Anti-inflammatory Broad-Spectrum Chemokine Inhibitors

David J. Fox, Jill Reckless, Hannah Lingard et al. · Journal of Medicinal Chemistry · 2009 · 33 citations

Rows per page

1–5 of 8